Administration of prosultiamine for HTLV-1-associated myelopathy may improve not only voiding symptoms but also storage symptoms by decreasing urinary nerve growth factor levels

Matsuo T1, Nakamura T2, Ohba K1, Mochizuki Y1, Miyata Y1, Sakai H1

Abstract Category

Pharmacology: Clinical

Abstract 696
Read By Title
Scientific Non Discussion Abstract Session 35
Pharmacology Voiding Dysfunction Detrusor Hypocontractility Detrusor Overactivity Underactive Bladder
1. Department of Urology, Nagasaki University School of Medicine, 2. Department of Molecular Microbiology and Immunology, Graduate School of Biomedical Sciences, Nagasaki University
Links

Abstract

17/12/2024 00:24:24